How Will AI Use in Biomanufacturing Be Regulated?

SandboxAQ’s SAIR dataset turns 5.2 M protein‑ligand structures into ground‑truth fuel for AI

SandboxAQ, the Alphabet spinoff whose name reflects its work at the intersection of AI and quantum techniques, thinks testing drugs on animals is already passé.

How Will AI Use in Biomanufacturing Be Regulated?

Drug industry regulators are embracing AI to streamline their oversight activities; however, say researchers, they are yet to make clear how they will regulate the use of the technology in manufacturing. In June, the FDA launched a generative AI tool—Elsa—to help scientific reviewers, investigators, and other staff work more efficiently. The agency also signaled its intention to integrate more AI into different regulatory processes. Likewise, on…